Anti-VEGFR2/KDR/CD309 Antibody (AlacizumAb)
Catalog No.
F1791
Anti-VEGFR2/KDR/CD309 Antibody (AlacizumAb)
Featured Products
Alacizumab (Anti-VEGFR2/KDR/CD309) is a humanized monoclonal antibody against VEGFR2/KDR/CD309. It has anti-tumor effects on tumor growth. Molecular weight: 144.08KD.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
144.08 kDa
Dry ice
934216-54-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
CDP791, g165 DFM-PEG
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P35968
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
VEGFR2 / KDR / CD309
Please avoid freeze-thaw cycles.